Michael Sorell
Keine laufenden Positionen mehr
Profil
Dr. Sorell is managing member of MS Capital., an investment banking & advisory firm.
He advised portfolio managers like JP Morgan, Merrill Lynch and corporations such as Onyx Pharmaceuticals, Alkermes, and DynaGen.
MS Capital raised capital for Roberts Pharmaceuticals, Xoma, and Cephalon.
From 1976 to 1983, he was on the attending staff of Memorial Sloan Kettering Cancer Center and a member of the faculty at Cornell University Medical College.
From 1983 to 1985, he was at Schering-Plough's clinical research division, responsible for the development of Interferon-a.
In 1986, he joined Morgan Stanley as a pharma & biotechnology analyst and was rated number one in stock picking from 1989 to 1992 (Greenwich Research survey).
He participated in equity issuances of over $2 billion (e.g.
Amgen, Chiron, MedImmune) as well as M&A activities in excess of $100 billion (e.g.
Bristol-Myers/Squibb, Chiron/Cetus, AHP/Genetics Institute, Sandoz/ Systemix).
In 1994, Dr. Sorell became the Emerging Growth Strategist at Morgan Stanley.
He is a Director of Corvas and a former Director of Selectide, DynaGen, and E-Med Technologies.
Dr. Sorell received his M.D.
from Albert Einstein College of Medicine, New York, his A.B.
from the University of Rochester, New York and his Advanced Professional Certificate (MBA) from New York University College of Business Administration.
Ehemalige bekannte Positionen von Michael Sorell
| Unternehmen | Position | Ende |
|---|---|---|
Applied NeuroSolutions, Inc.
 Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | Direktor/Vorstandsmitglied | 23.10.2007 |
NGN Capital LLC
 NGN Capital LLC Investment ManagersFinance NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York. | Direktor/Vorstandsmitglied | 09.07.2007 |
| NEUROLOGIX, INC. | Direktor/Vorstandsmitglied | 09.05.2007 |
| SCOLR PHARMA INC. | Direktor/Vorstandsmitglied | 20.04.2007 |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Analyst-Equity | 12.06.1997 |
Ausbildung von Michael Sorell
| Rochester Christian University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
SCOLR Pharma, Inc.
 SCOLR Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCOLR Pharma, Inc. is a pharmaceutical company, engages in proprietary and patented Controlled Delivery Technology platforms to develop and commercialize novel prescription, over-the-counter and nutritional products. The company's technology is used to develop dietary supplement products, including combinations of glucosamine and chondroitin, niacin, calcium, and other dietary products. Its lead product candidate is a CDT-based extended release formulation of ibuprofen, an analgesic typically used for the treatment of pain, fever and inflammation. SCOLR Pharma was founded in 1983 and is headquartered in Bellevue, WA. | Health Technology |
Neurologix, Inc.
 Neurologix, Inc. Internet Software/ServicesTechnology Services Neurologix, Inc. engages in the research, development and commercialization of life-altering gene transfer therapies for serious disorders of the brain and central nervous system. The company was founded by Martin J. Kaplitt 1978 and is headquartered in Fort Lee, NJ. | Technology Services |
Applied NeuroSolutions, Inc.
Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | Health Technology |
NGN Capital LLC
NGN Capital LLC Investment ManagersFinance NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York. | Finance |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Finance |
